# S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.

> **NCT04457323** · PHASE4 · UNKNOWN · sponsor: **Neutec Ar-Ge San ve Tic A.Ş** · enrollment: 126 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Metoprolol
- **DRUG:** Metoprolol

## Key facts

- **NCT ID:** NCT04457323
- **Lead sponsor:** Neutec Ar-Ge San ve Tic A.Ş
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-15
- **Primary completion:** 2022-10-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2021-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04457323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04457323, "S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04457323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*